Labiotech.eu

In Depth 16 Sep 2018

Meet the Entrepreneurs Doing Biotech from Shipping Containers in London

Creative biotech startups are brewing inside a shipping container park that offers affordable research space for biologists, engineers and designers working together. The space, called Open Cell, will be opening its doors to the public this week for the London Design Festival. Chip boards made using potato waste, construction materials made with fungi and crystals […]

September 16, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Sep 2018

Novozymes Releases Enzyme That Helps Chickens Better Absorb Food

Novozymes has released a new enzyme that breaks down bacterial cell debris in the gut and allows chickens to absorb more nutrients from their food. The Danish industrial biotech giant partnered with the Dutch health and nutrition company DSM to produce the bacterial muramidase enzyme solution, which is called ‘Balancius’. It has an interesting story […]

September 14, 2018 - 2 minutesmins - By Helen Albert

$bone Therapeutics cell therapy bone fracture$

News and Trends 14 Sep 2018

Cell Therapy Helps Regenerate Difficult Bone Fractures

All patients in a clinical trial run by the Belgian company Bone Therapeutics have seen an improvement in the healing of bone fractures that have had problems healing. Six months after receiving a single dose of the cell therapy developed by Bone Therapeutics, all 21 patients in the Phase I/IIa clinical trial met the primary […]

September 14, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Boehringer Ingelheim ViraTherapeutics oncolytic virus

More News! 13 Sep 2018

Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company

Boehringer Ingelheim is paying €210M to acquire all the remaining shares of ViraTherapeutics, an Austrian biotech company developing oncolytic viral therapies for cancer. ViraTherapeutics develops cancer therapies based on viruses that selectively kill tumor cells, based on the principle that cancer cells show defective mechanisms to defend themselves against viruses that are not able to […]

September 13, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Sep 2018

Airbus Will Use Recombinant Spider Silk to Build Lightweight Planes

Airbus has signed a partnership with German biotech AMSilk for the development of a new biomaterial to be used in the construction of future high-performance planes. Spider silk is known for having outstanding strength and flexibility. AMSilk uses engineered bacteria to produce spider silk protein, which is then used to create materials with a wide […]

September 12, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Helen Tayton Martin Adaptimmune interview

Interview 11 Sep 2018

How To Break Into The Crowded Immuno-Oncology Space

The field of immuno-oncology promises to make anti-cancer treatments more effective than ever. But in this crowded field, many companies struggle to make therapies that not only are effective and safe, but that can also be scaled-up, manufactured and commercialized. Helen Tayton-Martin, Chief Business Officer at the biotech company Adaptimmune, shares her advice on how […]

September 11, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Sep 2018

Cambridge Biotech Targets Artificial Pancreas Market With Fast Insulin and Stable Glucagon

UK biotech Arecor has raised €6.7M to help fund development of its extra-fast insulin and stable glucagon products for people with insulin-dependent diabetes. The speed of action of insulin has been a limiting factor for development of the artificial pancreas — a combined insulin pump and glucose monitor that would allow real-time control of blood […]

September 10, 2018 - 2 minutesmins - By Helen Albert

News and Trends 10 Sep 2018

Update: Non-Invasive Glucose Monitoring Device Moves Forward With Series B Funding

Update (10/09/2018): RSP Systems has raised an additional €3.85M that raises the total amount of its Series B fundraising to €10.35M. The funds will be used to run clinical trials with the company’s device, which measures blood sugar without the need for finger-pricking. Published on 11/06/2018 RSP Systems has raised €6.5M in the first closing […]

September 10, 2018 - 2 minutesmins - By Alexander Burik

Best in Biotech 10 Sep 2018

10 Biotech Companies in Berlin You Should Know

The vibrant startup scene of the German capital has attracted many biotechs to make it their home. Here are ten biotech companies in Berlin to keep an eye on. Well-known for its history and rich cultural scene, Berlin is also a hotspot for startups of all kinds (including us!). As the headquarters of the successful […]

September 10, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Sep 2018

More Brexit Bad News: EMA Pulls Contracts Early From UK Regulatory Body

The European Medicines Agency (EMA) has pulled all contracts with the UK’s medical regulation body ahead of the UK withdrawing from the EU next year. Until 2018, the EMA has relied on the UK Medicines & Healthcare products Regulatory Agency (MHRA) to assess 20–30% of its drugs on a contract basis, work worth approximately €15.6M […]

September 6, 2018 - 2 minutesmins - By Helen Albert

News and Trends 6 Sep 2018

Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics

In the midst of a legal litigation with Eli Lilly, Adocia has released Phase 1 data showing its insulin combo can outperform Lilly’s fast-acting insulin in keeping sugar levels low after a meal. The trial, which recruited 24 type 1 diabetics, studied the effect of Adocia’s BioChaperone pramlintide insulin on glucose levels right after […]

September 6, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Sep 2018

Cassava Plants Gene Edited Using CRISPR to Produce Waxy Starch

A team of European researchers applied CRISPR-Cas9 gene editing technology to engineer cassava plants that produce a modified type of starch, in demand for both cooking and industrial processing. The team also managed to speed up the flowering of the plants by introduction of a gene from Arabidopsis plants, which they hope will allow more […]

September 5, 2018 - 3 minutesmins - By Helen Albert

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Meet the Entrepreneurs Doing Biotech from Shipping Containers in London

Novozymes Releases Enzyme That Helps Chickens Better Absorb Food

Cell Therapy Helps Regenerate Difficult Bone Fractures

Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company

Airbus Will Use Recombinant Spider Silk to Build Lightweight Planes

How To Break Into The Crowded Immuno-Oncology Space

Cambridge Biotech Targets Artificial Pancreas Market With Fast Insulin and Stable Glucagon

Update: Non-Invasive Glucose Monitoring Device Moves Forward With Series B Funding

10 Biotech Companies in Berlin You Should Know

More Brexit Bad News: EMA Pulls Contracts Early From UK Regulatory Body

Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics

Cassava Plants Gene Edited Using CRISPR to Produce Waxy Starch

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!